Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > My previous 2 posts pretty much confirm ....
View:
Post by foofadooo on Jul 07, 2020 12:44pm

My previous 2 posts pretty much confirm ....

In my mind why the BLA is imminent.....this alliance wouldn't allow us in otherwise!

foof
Comment by sah1 on Jul 07, 2020 4:57pm
Foof, I believe The alliance allows Lmnl inside because it is willing to collect plasma from people who have had Covid which can then be used to manufacture a hyper immune containing Covid antibodies. What is interesting is that the alliance includes all the big players in plasma proteins, including ivig. In such company, I wouldn’t be surprised if interest will be expressed in Ryplazim in ...more  
Comment by foofadooo on Jul 07, 2020 6:38pm
You are probably correct although they are collecting both convalescent and regular plasma.....  Study Design: A randomized, placebo-controlled trial to determine whether immunoglobulin prepared from the pooled plasma from COVID-19 convalescent donors (COVID-IG) prevents infection with SARS-CoV-2 after IM administration. COVID-IG will be compared to immunoglobulin prepared from pooled plasma ...more  
Comment by foofadooo on Jul 07, 2020 7:02pm
https://stockhouse.com/news/press-releases/2017/12/18/prometic-s-plasminogen-ryplazim-granted-orphan-drug-designation-for-the    This old NR alludes to those thoughts.  foof
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities